{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:13:02Z","timestamp":1793146382769,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":301,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08 DK115886"],"award-info":[{"award-number":["K08 DK115886"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018719","name":"School of Medicine, University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Physiology"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.crphys.2025.100172","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:22:18Z","timestamp":1761949338000},"page":"100172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Role of obesity in chronic kidney disease progression"],"prefix":"10.1016","volume":"8","author":[{"given":"Austin","family":"Dada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-8074","authenticated-orcid":false,"given":"Ravi","family":"Nistala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib1","doi-asserted-by":"crossref","first-page":"R274","DOI":"10.1152\/ajpregu.00439.2005","article-title":"Renin receptor expression in human adipose tissue","volume":"292","author":"Achard","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mpd.2001.113006","article-title":"Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents","volume":"138","author":"Adelman","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.crphys.2025.100172_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-108187","article-title":"Relation between childhood obesity and adult cardiovascular risk","volume":"2009","author":"Allcock","year":"2009","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000341487","article-title":"DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy","volume":"36","author":"Alter","year":"2012","journal-title":"Kidney Blood Press. Res."},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ki.1997.111","article-title":"A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function","volume":"51","author":"Apperloo","year":"1997","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41591-024-03327-6","article-title":"Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial","volume":"31","author":"Apperloo","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.crphys.2025.100172_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1134644","article-title":"Obesity and renal disease: benefits of bariatric surgery","volume":"10","author":"Ardiles","year":"2023","journal-title":"Front. Med."},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib8","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/en.2013-1096","article-title":"Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male zucker obese rats","volume":"154","author":"Aroor","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.crphys.2025.100172_bib10","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1097\/01.ASN.0000141965.28037.EE","article-title":"Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?","volume":"15","author":"Bagby","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor\u2013associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00424-010-0860-y","article-title":"Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis","volume":"460","author":"Barton","year":"2010","journal-title":"Pflugers Arch."},{"issue":"12","key":"10.1016\/j.crphys.2025.100172_bib13","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1210\/clinem\/dgad330","article-title":"Obesity, hyperfiltration, and early kidney damage: a new formula for the estimation of creatinine clearance","volume":"108","author":"Basolo","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal lipid metabolism and lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2013.05.011","article-title":"Obesity, immunomodulation and chronic kidney disease","volume":"13","author":"Borgeson","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"8","key":"10.1016\/j.crphys.2025.100172_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00365518009095584","article-title":"Renal function and body composition before and after intestinal bypass operation in obese patients","volume":"40","author":"Br\u00f8chner-Mortensen","year":"1980","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib17","doi-asserted-by":"crossref","first-page":"F1647","DOI":"10.1152\/ajprenal.00082.2009","article-title":"Regulation of Na+\/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells","volume":"297","author":"Carraro-Lacroix","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib18","doi-asserted-by":"crossref","first-page":"F817","DOI":"10.1152\/ajprenal.2000.278.5.F817","article-title":"Glomerular hemodynamics in severe obesity","volume":"278","author":"Chagnac","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/01.ASN.0000068462.38661.89","article-title":"The effects of weight loss on renal function in patients with severe obesity","volume":"14","author":"Chagnac","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ekir.2017.01.010","article-title":"Bariatric surgery and kidney-related outcomes","volume":"2","author":"Chang","year":"2017","journal-title":"Kidney Int. Rep."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/oby.22134","article-title":"Metabolically healthy obesity and risk of kidney function decline","volume":"26","author":"Chang","year":"2018","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2006.07.025","article-title":"Podocyte lesions in patients with obesity-related glomerulopathy","volume":"48","author":"Chen","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.2006040327","article-title":"The enlarging body of evidence: obesity and chronic kidney disease","volume":"17","author":"Chertow","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.ajkd.2020.08.016","article-title":"Strategies to treat obesity in patients with CKD","volume":"77","author":"Chintam","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000446862","article-title":"Obesity, renin-angiotensin system blockade and risk of adverse renal outcomes: a population-based cohort study","volume":"43","author":"Cohen","year":"2016","journal-title":"Am. J. Nephrol."},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib28","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.crphys.2025.100172_bib29","first-page":"S175","article-title":"11. Chronic kidney disease and risk management: standards of medical care in Diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-022-00559-y","article-title":"Glomerular hyperfiltration","volume":"18","author":"Cortinovis","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib31","doi-asserted-by":"crossref","first-page":"F355","DOI":"10.1152\/ajprenal.00729.2010","article-title":"Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1","volume":"301","author":"Crajoinas","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"8","key":"10.1016\/j.crphys.2025.100172_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/dom.12925","article-title":"Effect of linagliptin on pulse wave velocity in early type 2 diabetes: a randomized, double-blind, controlled 26-week trial (RELEASE)","volume":"19","author":"de Boer","year":"2017","journal-title":"Diabetes Obes. Metabol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000105624.68174.00","article-title":"Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration","volume":"43","author":"de Paula","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00005373-199912000-00002","article-title":"Effect of increased renal venous pressure on renal function","volume":"47","author":"Doty","year":"1999","journal-title":"J. Trauma"},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib35","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk for chronic renal failure","volume":"17","author":"Ejerblad","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib36","first-page":"397","article-title":"Obesity and chronic kidney disease","volume":"31","author":"Eknoyan","year":"2011","journal-title":"Nefrologia"},{"issue":"11","key":"10.1016\/j.crphys.2025.100172_bib37","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1097\/01.ASN.0000133698.80390.37","article-title":"The relationship between hyperinsulinemia, hypertension and progressive renal disease","volume":"15","author":"El-Atat","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2796.2007.01852.x","article-title":"Obesity-induced inflammation: a metabolic dialogue in the language of inflammation","volume":"262","author":"Ferrante","year":"2007","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.crphys.2025.100172_bib39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999-2008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib41","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","article-title":"A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population","volume":"91","author":"Garofalo","year":"2017","journal-title":"Kidney Int."},{"issue":"49","key":"10.1016\/j.crphys.2025.100172_bib42","doi-asserted-by":"crossref","first-page":"46671","DOI":"10.1074\/jbc.M106897200","article-title":"Association of Na(+)-H(+) exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule","volume":"276","author":"Girardi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib43","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00174.2007","article-title":"Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule","volume":"294","author":"Girardi","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.crphys.2025.100172_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.crphys.2025.100172_bib46","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.2337\/dc13-0323","article-title":"Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction","volume":"36","author":"Groop","year":"2013","journal-title":"Diabetes Care"},{"issue":"5 Pt 2","key":"10.1016\/j.crphys.2025.100172_bib47","doi-asserted-by":"crossref","first-page":"49s","DOI":"10.1016\/S0895-7061(97)00075-7","article-title":"Mechanisms of abnormal renal sodium handling in obesity hypertension","volume":"10","author":"Hall","year":"1997","journal-title":"Am. J. Hypertens."},{"issue":"3 Pt 2","key":"10.1016\/j.crphys.2025.100172_bib48","first-page":"625","article-title":"The kidney, hypertension, and obesity","volume":"41","author":"Hall","year":"2003","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib49","first-page":"F366","article-title":"Control of glomerular filtration rate by renin-angiotensin system","volume":"233","author":"Hall","year":"1977","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.HYP.22.3.292","article-title":"Obesity-induced hypertension. Renal function and systemic hemodynamics","volume":"22","author":"Hall","year":"1993","journal-title":"Hypertension"},{"issue":"23","key":"10.1016\/j.crphys.2025.100172_bib51","doi-asserted-by":"crossref","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","article-title":"Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins","volume":"285","author":"Hall","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"10.1016\/j.crphys.2025.100172_bib53","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc22-1889","article-title":"Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000174256","article-title":"Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog","volume":"20","author":"Heller","year":"2008","journal-title":"Kidney Blood Press. Res."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/osp4.782","article-title":"Changes in glomerular filtration rate in patients with body mass index \u226535 kg\/m(2) treated with metabolic and bariatric surgery versus GLP-1 agonist at 1-year follow-up","volume":"10","author":"Henao-Carrillo","year":"2024","journal-title":"Obes. Sci. Pract."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib58","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/db06-0911","article-title":"Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation","volume":"56","author":"Hosogai","year":"2007","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib59","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","article-title":"The randle cycle revisited: a new head for an old hat","volume":"297","author":"Hue","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"8","key":"10.1016\/j.crphys.2025.100172_bib60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/CIRCRESAHA.115.308111","article-title":"CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli","volume":"118","author":"Itani","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.114.04631","article-title":"Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent","volume":"65","author":"Jackson","year":"2015","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.crphys.2025.100172_bib62","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00527.2014","article-title":"Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow","volume":"308","author":"Jensen","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib63","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","article-title":"Obesity and chronic kidney disease","volume":"324","author":"Jiang","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ehjcvp\/pvae094","article-title":"Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study","volume":"11","author":"Jimba","year":"2025","journal-title":"Eur Heart J. Cardiovascular Pharmacother."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib65","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.crphys.2025.100172_bib66","article-title":"Visceral fat and attribute-based medicine in chronic kidney disease","volume":"14, 1097596","author":"Kataoka","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib67","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","article-title":"The role of aldosterone in obesity-related hypertension","volume":"29","author":"Kawarazaki","year":"2016","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib68","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.crphys.2025.100172_bib69","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.3390\/nu13124482","article-title":"Impact of obesity in kidney diseases","volume":"13","author":"Kotsis","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.crphys.2025.100172_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117698669","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"4","author":"Kovesdy","year":"2017","journal-title":"Can J. Kidney Health Dis."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib72","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2005.06.007","article-title":"Obesity and prevalent and incident CKD: the hypertension detection and Follow-Up program","volume":"46","author":"Kramer","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib73","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","article-title":"Increasing body mass index and obesity in the incident ESRD population","volume":"17","author":"Kramer","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.crphys.2025.100172_bib74","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3390\/biomedicines11092498","article-title":"Obesity-related kidney disease: current understanding and future perspectives","volume":"11","author":"Kreiner","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib75","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfq522","article-title":"Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients","volume":"26","author":"Lamacchia","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.ajkd.2014.06.016","article-title":"Gastric bypass surgery and measured and estimated GFR in women","volume":"64","author":"Lieske","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/biology13040241","article-title":"Overnutrition and lipotoxicity: impaired efferocytosis and chronic inflammation as precursors to multifaceted disease pathogenesis","volume":"13","author":"Mann","year":"2024","journal-title":"Biology"},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib78","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/HYPERTENSIONAHA.110.156554","article-title":"Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans","volume":"56","author":"Marney","year":"2010","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13450","article-title":"Obesity-related glomerulopathy: current approaches and future perspectives","volume":"23","author":"Mart\u00ednez-Montoro","year":"2022","journal-title":"Obes. Rev."},{"key":"10.1016\/j.crphys.2025.100172_bib80","article-title":"Impact of proximal tubule-specific deletion of dipeptidyl peptidase 4 on blood pressure, renal sodium handling, and NHE3 phosphorylation","author":"Martins","year":"2024","journal-title":"bioRxiv [Preprint]. 2024 Dec 23:2024.12.22.629982"},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/157339911794273928","article-title":"Obesity related kidney disease","volume":"7","author":"Mathew","year":"2011","journal-title":"Curr. Diabetes Rev."},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib82","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.1997.273.3.E650","article-title":"Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle","volume":"273","author":"Meyer","year":"1997","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.crphys.2025.100172_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100502","article-title":"Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: a review of their kidney and heart protection","volume":"14","author":"Michos","year":"2023","journal-title":"Am J. Prev. Cardiol."},{"issue":"10","key":"10.1016\/j.crphys.2025.100172_bib84","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib85","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI115335","article-title":"Glomerular function in pima Indians with noninsulin-dependent diabetes mellitus of recent onset","volume":"88","author":"Myers","year":"1991","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.crphys.2025.100172_bib86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"S3","key":"10.1016\/j.crphys.2025.100172_bib87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.14496","article-title":"The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update","volume":"23","author":"Nauck","year":"2021","journal-title":"Diabetes Obes. Metabol."},{"issue":"10","key":"10.1016\/j.crphys.2025.100172_bib88","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.02250409","article-title":"Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/osp4.629","article-title":"Obesity and chronic kidney disease: a current review","volume":"9","author":"Nawaz","year":"2023","journal-title":"Obes. Sci. Pract."},{"key":"10.1016\/j.crphys.2025.100172_bib90","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00316.2016","article-title":"Diabetes, hypertension and chronic kidney disease progression: role of DPP4","author":"Nistala","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol. 312 (4), F661-F670."},{"issue":"12","key":"10.1016\/j.crphys.2025.100172_bib91","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/ars.2008.2034","article-title":"Redox control of renal function and hypertension","volume":"10","author":"Nistala","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"10.1016\/j.crphys.2025.100172_bib92","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/oby.20833","article-title":"DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat","volume":"22","author":"Nistala","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.crphys.2025.100172_bib93","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1210\/en.2013-1920","article-title":"Prevention of obesity-induced renal injury in male mice by DPP4 inhibition","volume":"155","author":"Nistala","year":"2014","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib94","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1152\/ajprenal.00565.2020","article-title":"DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice","volume":"320","author":"Nistala","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"13","key":"10.1016\/j.crphys.2025.100172_bib95","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.crphys.2025.100172_bib96","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib98","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.mayocp.2022.01.012","article-title":"Metabolic flexibility and its impact on health outcomes","volume":"97","author":"Palmer","year":"2022","journal-title":"Mayo Clin. Proc."},{"issue":"16","key":"10.1016\/j.crphys.2025.100172_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158451","article-title":"Metabolic changes in aging humans: current evidence and therapeutic strategies","volume":"132","author":"Palmer","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.crphys.2025.100172_bib100","article-title":"The association between visceral adiposity index and chronic kidney disease in the elderly: a cross-sectional analysis of NHANES 2011-2018","volume":"35","author":"Peng","year":"2023","journal-title":"Prev. Med. Rep."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000447674","article-title":"The fatty kidney: obesity and renal disease","volume":"136","author":"Praga","year":"2017","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.crphys.2025.100172_bib103","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.2014.10706","article-title":"Long-term follow-up after bariatric surgery: a systematic review","volume":"312","author":"Puzziferri","year":"2014","journal-title":"JAMA"},{"issue":"7285","key":"10.1016\/j.crphys.2025.100172_bib104","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle","year":"1963","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI114470","article-title":"Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat","volume":"85","author":"Remuzzi","year":"1990","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.crphys.2025.100172_bib106","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00259.2012","article-title":"Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice","volume":"303","author":"Rieg","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semnephrol.2012.12.002","article-title":"The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases","volume":"33","author":"R\u00fcster","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"4 Suppl. 2","key":"10.1016\/j.crphys.2025.100172_bib108","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1681\/ASN.2005121321","article-title":"Obesity, arterial stiffness, and cardiovascular risk","volume":"17","author":"Safar","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0197-3118.2006.05470.x","article-title":"Cardiometabolic syndrome and chronic kidney disease: what is the link?","volume":"1","author":"Sarafidis","year":"2006","journal-title":"J. Cardiometabolic Syndrome"},{"issue":"14","key":"10.1016\/j.crphys.2025.100172_bib110","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.crphys.2025.100172_bib111","first-page":"1645","article-title":"Adiponectin regulates albuminuria and podocyte function in mice","volume":"118","author":"Sharma","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.crphys.2025.100172_bib112","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1681\/ASN.2013040330","article-title":"Obesity in CKD--what should nephrologists know?","volume":"24","author":"Stenvinkel","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.crphys.2025.100172_bib113","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41419-020-03122-4","article-title":"High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.crphys.2025.100172_bib114","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00125-018-4669-0","article-title":"The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure","volume":"61","author":"Thomas","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ekir.2017.01.007","article-title":"The renal pathology of obesity","volume":"2","author":"Tsuboi","year":"2017","journal-title":"Kidney Int. Rep."},{"issue":"4","key":"10.1016\/j.crphys.2025.100172_bib116","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/dc14-1850","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial","volume":"38","author":"Udell","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.crphys.2025.100172_bib117","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1113\/expphysiol.2014.078766","article-title":"Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4","volume":"99","author":"Vallon","year":"2014","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib118","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12882-017-0474-0","article-title":"Effect of large weight reductions on measured and estimated kidney function","volume":"18","author":"von Scholten","year":"2017","journal-title":"BMC Nephrol."},{"issue":"3","key":"10.1016\/j.crphys.2025.100172_bib119","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2215\/CJN.04071206","article-title":"Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease","volume":"2","author":"Wahba","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib120","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1038\/s41598-024-55724-z","article-title":"The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function","volume":"14","author":"Wajdlich","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib121","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semnephrol.2012.12.006","article-title":"Obesity and kidney disease: potential mechanisms","volume":"33","author":"Wickman","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.crphys.2025.100172_bib122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2015.08.001","article-title":"Diet-induced obesity and kidney disease - in search of a susceptible mouse model","volume":"124","author":"Wicks","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.crphys.2025.100172_bib123","article-title":"World obesity Atlas 2024","volume":"2024","year":"2024","journal-title":"World Obes. Feder."},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.ajkd.2010.03.017","article-title":"Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population","volume":"56","author":"Wuerzner","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.crphys.2025.100172_bib125","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/ph16091256","article-title":"Targeting renal proximal tubule cells in obesity-related glomerulopathy","volume":"16","author":"Ye","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.crphys.2025.100172_bib126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/HJH.0000000000000782","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"34","author":"Zhang","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.crphys.2025.100172_bib127","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3389\/fimmu.2019.01050","article-title":"DPP-4 inhibitors as potential candidates for antihypertensive therapy: improving vascular inflammation and assisting the action of traditional antihypertensive drugs","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.crphys.2025.100172_bib128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Current Research in Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665944125000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665944125000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T08:00:49Z","timestamp":1766044849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665944125000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":128,"alternative-id":["S2665944125000343"],"URL":"https:\/\/doi.org\/10.1016\/j.crphys.2025.100172","relation":{},"ISSN":["2665-9441"],"issn-type":[{"value":"2665-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of obesity in chronic kidney disease progression","name":"articletitle","label":"Article Title"},{"value":"Current Research in Physiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphys.2025.100172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100172"}}